BEAR OPEN END TURBO WARRANT - GALAPAGOS Stock

BEAR OPEN END TURBO WARRANT - GALAPAGOS Share Price

Certificat

35B6H

DE000GX8JMW7

Market Closed - Euronext Paris 11:00:01 25/11/2022 pm IST
5.16 ^EUR	-0.77%

1 month	+11.45%
3 months	+29.65%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart GALAPAGOS NV

Chart BEAR OPEN END TURBO WARRANT - GALAPAGOS

Latest news about GALAPAGOS NV

Galapagos : Galapagos creates new subscription right plans	17/05	PU
Galapagos creates new subscription right plans	17/05	GL
Galapagos Partners with Blood Centers of America to Decentralize CAR-T Cell Therapy Manufacture	16/05	MT
Galapagos and Blood Centers of America announce strategic collaboration to accelerate Galapagos’ decentralized CAR-T manufacturing network in the U.S.	16/05	GL

More news

Static data

Product type	Knock-Out without Stop Loss
Buy / Sell	PUT
Underlying	GALAPAGOS NV
Issuer	Goldman Sachs
	35B6H
ISIN	DE000GX8JMW7
Date issued	04/02/2022
Strike	89.08 €
Maturity	Unlimited
Parity	10 : 1
Emission price	3.8 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	5.21 €
Lowest since issue	2.84 €
Spread	0.03 €
Spread %	0.58%

Company Profile

Galapagos NV is a fully integrated biotechnology company focused on discovering, developing, and commercializing innovative medicines. The company is committed to improving patients' lives worldwide by targeting diseases with high unmet needs. Its R&D capabilities cover multiple drug modalities, including small molecules and cell therapies. Its portfolio comprises discovery through to commercialized programs in immunology, oncology, and other indications. Its first medicine for rheumatoid arthritis and ulcerative colitis is available in Europe and Japan.

Sector

More about the company